Financial Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences Share by Ken Dropiewski on January 22, 2019 More in Financial: CorVista Health Announces New AMA Category III CPT® Code for Augmentative AI Analysis of Cardiopulmonary Disease July 1, 2026 Idorsia appoints Roland Wandeler as Chief Executive Officer June 30, 2026 MarinHealth Launches the Haynes Heart and Vascular Institute, Marking a New Era in Cardiovascular Care for the North Bay June 30, 2026 Share this story Facebook Twitter LinkedIn